Am J Alzheimers Dis Other Demen
Adaptation, PsychologicalAlzheimer DiseaseCognitive Dysfunction
Dr. Michael S. Mega, MD, PhD
NPI1437186038
- Part D claims, 2024
- 138
- Publications
- 1
- Clinical trials
- 10
- Hospital affiliations
- 1
- Industry payments
- $13,060
- Practice address
- 3181 SW Sam Jackson Park Road, Portland, OR 97239
- Practice phone
- Call (503) 494-9000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Mega's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Michael S. Mega is a neurologist in Portland, Oregon
Dr. Mega practices at OHSU Hospital in Portland, Oregon, part of State of Oregon.
Dr. Mega's NPI, 1437186038, was assigned on June 27, 2006. Dr. Mega holds Oregon license MD18185.
NPI and contact details
- NPI
- 1437186038NPI Registry (opens in a new tab)
- NPI enumeration date
- June 27, 2006
- NPI status
- Active
- Practice phone
- (503) 494-9000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Michael S. Mega practices at OHSU Hospital in Portland, Oregon
Dr. Mega's primary practice is OHSU Hospital, at 3181 SW Sam Jackson Park Road, Portland, OR 97239 in Multnomah County. The practice phone is (503) 494-9000.
- OHSU Hospital3181 SW Sam Jackson Park Road, Portland, OR 97239 · Multnomah CountyPhone(503) 494-9000
Source: Dmand AI Affiliation Data
Dr. Michael S. Mega is affiliated with 2 sites of care
Dr. Mega's primary practice is OHSU Hospital in Portland, Oregon, part of State of Oregon. Dmand AI also links Dr. Mega to 1 clinical lab, named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Michael S. Mega's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mega practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| OHSU Hospital | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Mega practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across State of Oregon and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Michael S. Mega is one of 246 neurologists in Oregon
Neurology is Dr. Mega's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Mega is licensed in Oregon.
Specialties and state licenses
- Neurology, OregonPrimary
Neurologists near Dr. Mega
Counts of neurologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Michael S. Mega's patients have a median age of 74
Across all payers, Dmand AI patient panel data puts Dr. Mega's median patient age at 74, with 58% women.
Dr. Mega's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 74
Patient panel by sex, all payers
- Women58%
- Men42%
Source: Dmand AI Patient Panel Data
Dr. Michael S. Mega wrote 138 Medicare Part D claims in 2024
In 2024, Dr. Mega wrote 138 Medicare Part D claims for 18 patients. 92% of them were for generic drugs. CMS names the drug for 87 of them, across 3 drugs with 11 or more claims each, at $3,610 in total drug cost. In 2023, CMS named 119 claims across 4 drugs.
Part D claims, 2024138
Drugs named by CMS3
Total drug cost$3,610
Part D patients18
Dr. Mega's Part D claims by kind of drug, 2024
- Generic127 claims92%
- Brand-name11 claims8%
Dr. Mega's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Mega's Part D claims, 2024
- Antipsychotics, patients 65 and over14%20 of 138 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1192024: 8727%
Drugs named by CMS: 3 in 2024, 4 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Find neurologists like Dr. Mega by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Michael S. Mega has 1 publication on record
Dmand AI links 1 paper to Dr. Mega.
Papers1
Recent publications by Dr. Mega
See who Dr. Mega researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Mega works with, so you can find a warm path to the right neurologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Michael S. Mega has worked on 10 clinical trials
Dmand AI links Dr. Mega to 10 clinical trials, 2 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Alzheimer Disease, Tauopathies and Plaque, Amyloid. Eli Lilly and Company sponsors the most, 4. Open Payments lists research payments to Dr. Mega that name 3 trials.
Clinical trials with Dr. Mega by phase
- NonePhase 1: no trials
- 2Phase 2: 2 trials
- 1Phase 2/3: 1 trial
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Dr. Mega's trials
- Alzheimer Disease
- Tauopathies
- Plaque, Amyloid
- Cognitive Dysfunction
- Deafness, Autosomal Recessive 39
Investigators on the most trials with Dr. Mega
- Richard F. Holub, MD7 shared trials
- Mark Goldstein, MD5 shared trials
- Kimball Anne Johnson, MD5 shared trials
Recent clinical trials with Dr. Mega
A Randomized, Placebo-Controlled, Double-Blind Study of ATH-1017 Treatment in Subjects With Mild to Moderate Alzheimer's Disease (opens in a new tab)
CompletedPhase 2/3
Alzheimer DiseaseTauopathiesATH-1017
Deafness, Autosomal Recessive 39Lewy Body DiseaseATH-1017
A Randomized, Placebo-Controlled, Translational Study of ATH-1017 in Subjects With Mild to Moderate Alzheimer's Disease (opens in a new tab)
CompletedPhase 2
Memory DisordersAlzheimer DiseaseATH-1017
Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease (opens in a new tab)
TerminatedPhase 3
Alzheimer DiseaseTauopathiesSimufilam
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Michael S. Mega received $13,060 in industry payments from 2016 to 2024
CMS Open Payments shows 24 general payments to Dr. Mega from 4 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 52% of the total. Biogen, Inc. paid the most, $11,604. It also lists 19 research payments totaling $19,296 from 2016 to 2023, naming 3 clinical trials.
General payments to Dr. Mega by program year, 2016 to 2024
General payments to Dr. Mega by kind, 2016 to 2024
$13.1Kin total
- Speaker and faculty fees$6,78052%
- Consulting fees$4,80837%
- Travel and lodging$9427%
- Food and beverage$4654%
- Education$650%
Companies that paid Dr. Mega the most, 2016 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Michael S. Mega's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Michael S. Mega
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Michael S. Mega's NPI number?
Dr. Michael S. Mega's NPI number is 1437186038. It was assigned on June 27, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Michael S. Mega?
Dr. Michael S. Mega is a neurologist in Portland, Oregon. The primary specialty in the NPI Registry is Neurology Physician (taxonomy code 2084N0400X).
Where does Dr. Michael S. Mega practice?
Dr. Mega practices at 3181 SW Sam Jackson Park Road, Portland, OR 97239. Dr. Mega's primary practice is OHSU Hospital in Portland, Oregon, part of State of Oregon. Dmand AI also links Dr. Mega to 1 clinical lab.
What is Dr. Michael S. Mega's office phone number?
The practice phone on file for Dr. Mega is (503) 494-9000.
What is Dr. Michael S. Mega's medical license number?
Dr. Mega holds Oregon license MD18185.
Which hospitals is Dr. Michael S. Mega affiliated with?
Dr. Mega practices at OHSU Hospital in Portland, Oregon.
What drugs does Dr. Michael S. Mega prescribe most?
In 2024 Medicare Part D data, Dr. Mega's most prescribed drugs by claims were Donepezil HCl, Rivastigmine and Citalopram HBr.
Has Dr. Michael S. Mega received payments from drug or device companies?
CMS Open Payments shows $13,060 in general payments to Dr. Mega from 4 companies from 2016 to 2024. The largest total came from Biogen, Inc.
How long has Dr. Michael S. Mega been practicing?
Dr. Mega's NPI was assigned in 2006.
Does Dr. Michael S. Mega do research?
Dmand AI links 1 publication to Dr. Mega. Dr. Mega has worked on 10 clinical trials.
Selling to neurology practices?
See neurologists in Oregon by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card